CompletedNot Applicable

Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss

Italy240 participantsStarted 2024-11-04

Plain-language summary

The goal of this study was to learn if dietary supplement in capsules and drinkable works to help hair loss in volunteers with chronic telogen effluvium and androgenetic alopecia and learn about its safety. The main questions it aims to answer are: * Does dietary supplement in capsules and drinkable reduces hair loss in women and men suffering from chronic telogen effluvium or androgenetic alopecia? * Were the products well accepted by the subjects from their´s perspective? Researchers will compare dietary supplement in capsules and drinkable to a placebo (a look-alike substance that contains no active ingredients) to see if dietary supplements works to reduce hair loss. Participants will: * Take assigned diatry supplement in capsule or drinkable or a placebo every day for 6 months * Visit the study facility once every 3 months for evaulations * Keep a diary of the product use

Who can participate

Age range18 Years – 62 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy female and male subjects, including at least 70% female subjects aged over 30 years old ✓ Caucasian ethnicity * Aged between 18 and 62 years old (extreme included) * 50% of subjects with chronic telogen effluvium (stage from 2 to 4, according to Sinclair scale for female pattern hair loss in women and modified Sinclair scale for female pattern hair loss in men) * 50% of subjects with androgenetic alopecia (AGA): female subjects Ludwig scale (score I-II) and male subjects Hamilton- Norwood scale (vertex II-III) * Subjects aware of the study procedures and having signed an informed consent form * Subjects registered with National Health Service (NHS) * Subjects certifying the truthfulness of the personal data disclosed to the investigator * Subjects able to understand the language used in the investigation and to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements * The pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) should be stable for at least one month without any changes expected or planned during the study * Commitment not to change the daily routine or the lifestyle * Subject informed about the study procedures and having signed the privacy policy Exclusion Criteria: * Subjects who do not fit the inclusion criteria. * Subjects with acute or chronic diseases able to interfere with the outcome of the study or that are con…

What they're measuring

Change from Baseline in the hair density at 3 and 6 months

Timeframe: From the baseline, at 3 months and at the end of the study (6 months).

Trial details

NCT IDNCT07358403

SponsorLacer S.A.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-09-26